Type Ii Hypersensitivity

Type II Hypersensitivity is a form of immune-mediated tissue damage characterized by the binding of immunoglobulin G (IgG) or immunoglobulin M (IgM) antibodies to cell-surface antigens, leading to cellular destruction through complement activation, antibody-dependent cellular cytotoxicity, or opsonization.

459

Publications

20K

Citations

2K

Authors

573

Institutions

Publications per year

2017–2026

41

Authors

2K

  1. KI
    Kimishige Ishizaka

    Johns Hopkins University, United States

    14 publications · 724 citations

    14

    h-index

  2. ZÓ
    Zoltán Óváry

    New York University, United States

    5 publications · 198 citations

    6

    h-index

  3. DH
    Daniel H. Conrad

    Virginia Commonwealth University, United States

    5 publications · 198 citations

    5

    h-index

  4. HO
    Hirokazu Okudaira

    The University of Tokyo, Japan

    4 publications · 79 citations

    4

    h-index

  5. HK
    Hajime Kimata

    Kyoto University Hospital, Japan

    4 publications · 188 citations

    4

    h-index

1–5 of 2K

Venues

  1. PubMed

    Repository · 83 publications · 3.4K citations

    33

    h-index

  2. Journal of Allergy and Clinical Immunology

    38 publications · 2.6K citations

    25

    h-index

  3. The Journal of Immunology

    JI · 29 publications · 1.7K citations

    21

    h-index

  4. 17

    h-index

  5. The Journal of Experimental Medicine

    13 publications · 737 citations

    12

    h-index

1–5